Results 101 to 110 of about 26,604 (250)
Transfusion Medicine, EarlyView.Abstract Objective This study aimed to analyse the distribution and demand patterns of antigen‐negative red blood cells (RBCs) in Shandong Province, China (2022–2024), with a focus on ABO blood groups and clinically significant antigens. The research was designed to provide rigorous data for advancing precision transfusion protocols and to establish a ...
Aiping Zhao +7 more
wiley +1 more source
Transfusion, EarlyView.Abstract Background RhD mismatched transfusions in RhD negative women have the potential to impact future pregnancies through alloimmunization and development of hemolytic disease of the fetus and newborn (HDFN). As use of RhD positive emergency‐release blood products in pediatric trauma has increased, it has become clear that a significant ...
Kirea Lange +7 more
wiley +1 more source
Transfusion, EarlyView.Abstract Background ABO blood groups may be associated with increased risk for several diseases including cardiovascular diseases (CVDs), particularly coronary heart disease (CHD). The role of other significant blood group systems, such as RhD and RhCE, has not been extensively investigated.
Surendra Karki +4 more
wiley +1 more source
Deceased donor ABO discrepancy due to a rare AwB subgroup: Implications for organ allocation
Transfusion, EarlyView.Abstract Background Accurate ABO determination is critical for safe deceased donor organ allocation. Weak or variant ABO subgroups may not be reliably detected by routine serologic testing, especially under urgent conditions or following transfusion. Such limitations can result in discrepant ABO assignments with potential implications for transplant ...
Sara O. Dionne +3 more
wiley +1 more source
Transfusion, EarlyView.Abstract Background Therapeutic plasma exchange (TPE) using exclusively albumin replacement fluid depletes coagulation factors, particularly fibrinogen, and concerns about performing multiple consecutive daily procedures due to iatrogenic bleeding exist. Fibrinogen testing to guide bleeding risk stratification is vague.
Jay S. Raval +7 more
wiley +1 more source
Revealing and quantifying polyclonal anti‐A, B specificity in ABO histo‐blood groups
Transfusion, EarlyView.Abstract Background The clinically significant antibody anti‐A,B together with anti‐A and anti‐B has been known for many decades to be present in blood group O plasma. As anti‐A,B is only reactive when an A or B antigen is present, its contribution to titer cannot be easily distinguished from anti‐A and/or anti‐B.
Stephen Henry +6 more
wiley +1 more source
Sokoto Journal of Medical Laboratory Science, 2018 The interplay between malaria parasites and blood group antigens remains a fascinating subject with potential to contribute to the development of new interventions to reduce the global burden of malaria.
Danladi, S.B., Garba, N., Buhari, D.U.
doaj
Transfusion, EarlyView.Abstract Background Transfusion‐related alpha‐gal syndrome (TRAGS) has recently been proposed as a cause of allergic transfusion reactions (ATRs) in which alpha‐gal‐specific IgE in sensitized group O (or potentially group A) recipients reacts with epitopes on group B or AB plasma‐containing components.
Mackenzie Foster +9 more
wiley +1 more source